HLS Therapeutics (HLTRF, $2.79) was a top loser this month, diving -2 to $2.79 per share. Of the 277 stocks analyzed in the Pharmaceuticals: Other Industry throughout this month, of them (5) exhibited an Uptrend while of them (4) were in a Downtrend.